序号 |
标题 |
次数 |
作者 |
发布时间 |
72811 |
MC-PEG4-EDA-PNU, ADC试剂 |
125 |
kx |
2024-12-19 |
72812 |
cas:2055024-54-7 Boc-PEG4-Val-Cit-PAB-OH |
114 |
zyl |
2024-12-19 |
72813 |
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB-PNP(CAS: 2055042-82-3) |
100 |
WYQ |
2024-12-19 |
72814 |
Mal-amido-PEG8-val-gly-PAB-OH(CAS: 2353409-52-4) |
105 |
WYQ |
2024-12-19 |
72815 |
cas:160854-54-6,4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene,ADC定制 |
86 |
wyh |
2024-12-19 |
72816 |
cas:2504147-59-3 MC (C5)-Val-Cit |
124 |
zyl |
2024-12-19 |
72817 |
Boc-PEG4-Val-Ala-PAB,可降解的ADC连接体 |
135 |
WYQ |
2024-12-19 |
72818 |
cas:2058075-34-4,DGN549-C , ADC试剂 |
72 |
kx |
2024-12-19 |
72819 |
CAS: 1639939-40-4,Mal-Val-Ala-PAB-PNP,马来酰亚胺-VAL-ALA-PAB-PNP |
122 |
WYQ |
2024-12-19 |
72820 |
Fmoc-VC-PAB-Duocarmycin SA, ADC试剂 |
95 |
kx |
2024-12-19 |
72821 |
Mal-PEG4-Val-Ala-PAB,可降解的ADC(抗体偶联药物)连接子 |
153 |
WYQ |
2024-12-19 |
72822 |
Mal-PEG1-Val-Cit-OH的介绍 |
123 |
zyl |
2024-12-19 |
72823 |
MC-vc-PAB-Monomethyl dolastatin10, ADC试剂 |
83 |
kx |
2024-12-19 |
72824 |
CAS: 1870916-87-2,Mal-Val-Ala-PAB,马来酰亚胺-缬氨酸-丙氨酸-对氨基苯甲酸 |
89 |
WYQ |
2024-12-19 |
72825 |
cas:2395887-69-9 Mal-PEG2-Val-Cit-PAB-PNP |
84 |
zyl |
2024-12-19 |
72826 |
SuO-Val-Cit-PAB-MMAE, ADC试剂 |
74 |
kx |
2024-12-19 |
72827 |
Mal-PEG4-Val-Ala-PAB-PNP的介绍 |
87 |
zyl |
2024-12-19 |
72828 |
CAS: 2348405-93-4,DBCO-PEG4-Val-Ala-PAB-PNP |
63 |
WYQ |
2024-12-19 |
72829 |
CAS: 2348405-92-3,DBCO-PEG4-Val-Ala-PAB |
76 |
WYQ |
2024-12-19 |
72830 |
cas:2112738-13-1 Mal-amido-PEG2-Val-Cit-PAB-PNP |
78 |
zyl |
2024-12-19 |
72831 |
Azido-PEG4-Val-Ala-PAB,分子式:C29H48N8O9 |
67 |
WYQ |
2024-12-19 |
72832 |
cas:2055896-86-9,MC-Val-Cit-PAB-tubulysin5a , ADC试剂 |
85 |
kx |
2024-12-19 |
72833 |
Azido-PEG8-Val-Cit-PAB-PNP |
64 |
zyl |
2024-12-19 |
72834 |
cas:2055896-83-6,MC-Val-Cit-PAB-carfilzomib , ADC试剂 |
106 |
kx |
2024-12-19 |
72835 |
MAL-di-EG-Val-Cit-PAB-MMAF, ADC试剂 |
76 |
kx |
2024-12-19 |
72836 |
cas:2353409-45-5 endo BCN-PEG3-VC-PFP Ester |
87 |
zyl |
2024-12-19 |
72837 |
Hydrazone-doxorubicin, ADC试剂 |
156 |
kx |
2024-12-19 |
72838 |
DBCO-C4-Val-Cit-PABC-PNP |
64 |
zyl |
2024-12-19 |
72839 |
cas:644981-35-1 Val-Cit-PAB-MMAE |
76 |
zyl |
2024-12-19 |
72840 |
cas:170908-81-3,DOTA-NHS ester ,1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 |
69 |
kx |
2024-12-19 |
72841 |
endo-BCN-PEG4-Val-Cit-PAB-MMAE的介绍 |
75 |
zyl |
2024-12-19 |
72842 |
cas:2259318-50-6,MA-PEG4-VA-PBD , ADC试剂 |
91 |
kx |
2024-12-19 |
72843 |
CAS: 2259318-55-1 - DBCO-(PEG2-VC-PAB-MMAE)2 |
59 |
WYQ |
2024-12-19 |
72844 |
CAS: 2768446-73-5,DBCO-Val-Cit-PAB-MMAE |
72 |
WYQ |
2024-12-19 |
72845 |
MC-vc-PAB-C6-a-amanitin, ADC试剂 |
62 |
kx |
2024-12-19 |
72846 |
cas:663598-98-9,2,5-dioxopyrrolidin-1-yl 4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoate,ADC定制 |
78 |
wyh |
2024-12-19 |
72847 |
cas:2873452-49-2 MC-EVCit-PAB-MMAE |
82 |
zyl |
2024-12-19 |
72848 |
2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate,ADC定制 |
88 |
wyh |
2024-12-19 |
72849 |
cas:159857-70-2 MC-Val-Cit-Doxorubicin |
110 |
zyl |
2024-12-19 |
72850 |
Gly3-vc-PAB-MMAE, ADC试剂 |
90 |
kx |
2024-12-19 |
72851 |
CAS: 1869126-64-6, Azido-PEG4-Val-Cit-PAB-MMAE |
72 |
WYQ |
2024-12-19 |
72852 |
cas:2353409-54-6 , Mal-amido-PEG8-Val-Gly,ADC定制 |
88 |
wyh |
2024-12-19 |
72853 |
Azido-PEG4-Val-Ala-PAB-PNP |
87 |
zyl |
2024-12-19 |
72854 |
NOTA-(NGR)2 NOTA偶联NGR二聚体 |
74 |
h |
2024-12-19 |
72855 |
1-(2,5-dioxopyrrolidin-1-yloxy)-4-((5-nitropyridin-2-yl)disulfanyl)-1-oxobutane-2-sulfonic acid,ADC定制 |
82 |
wyh |
2024-12-19 |